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Abstract Only a minority of individuals who undergo
cancer genetic counseling experience heightened levels of
psychological distress, but many more experience a range of
cancer genetic-specific psychosocial problems. The aim of
this study was to estimate the prevalence of such psychosocial
problems, and to identify possible demographic and clinical
variables associated significantly with them. Consenting in-
dividuals scheduled to undergo cancer genetic counseling
completed the Psychosocial Aspects of Hereditary Cancer
(PAHC) questionnaire, the Hospital Anxiety and Depression
Scale (HADS) and the Distress Thermometer (DT) prior to or
immediately following their counseling session. More than
half of the 137 participants reported problems on three or
more domains of the PAHC, most often in the domains
‘living with cancer’ (84 %), ‘family issues’ (46 %), ‘heredi-
tary predisposition’ (45 %), and ‘child-related issues’ (42 %).
Correlations between the PAHC, the HADS and the DT were
low. Previous contact with a psychosocial worker, and having
a personal history of cancer were associated significantly with
HADS scores, but explained little variance (9 %). No back-
ground variables were associated significantly with the DT.
Previous contact with a psychosocial worker, and having
children were significantly associated with several PAHC
domains, again explaining only a small percentage of the
variance (2–14 %). The majority of counselees experience
specific cancer genetic counseling-related psychosocial
problems. Only a few background variables are associated
significantly with distress or psychosocial problems. Thus we
recommend using the PAHC or a similar problem-oriented
questionnaire routinely in cancer genetic counseling to iden-
tify individuals with such problems.
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Introduction
One of the main messages of studies on the psychosocial
impact of genetic counseling for cancer is that, after the
process of genetic counseling and risk assessment has been
completed, distress levels for the majority of counselees
return to or are even lower than baseline levels [1–3].
However, approximately one-quarter of counselees expe-
rience heightened levels of distress during and/or after the
genetic counseling process [4].
The psychosocial impact of genetic counseling is most
frequently measured with the Hospital Anxiety and De-
pression scale (HADS), the State Trait Anxiety Inventory,
the Impact of Event Scale, or the Center for Epi-
demiological Studies Depression Scale [5–7]. However,
these questionnaires may be too generic to capture the
entire spectrum of psychosocial issues relevant to the
cancer genetic setting [8]. They do not capture other im-
portant issues and concerns, such as existential problems,
family related problems, issues surrounding genetic risk,
the burden of living with cancer, and possible practical
problems related to genetic counseling (e.g., insurance is-
sues) [8–10].
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Several methods are available to assist genetic coun-
selors in detecting counselees with serious psychosocial
problems. It has been proposed to use sociodemographic
and clinical risk factors to identify (potentially) distressed
individuals [11, 12]. Vadaparampil et al. [7] recommend
inquiring routinely about previous contacts with psy-
chosocial caregivers as a means of identifying counselees
potentially in need of such services.
Increasingly, the Distress Thermometer (DT) with an
accompanying problem checklist is being recommended as
a first line screening method for distress in daily clinical
oncology practice [13]. The DT, together with a revised
checklist designed specifically for women at high risk of
developing breast cancer has proven to be useful in
screening for distress at the time women undergo mam-
mography [14].
Recently, we developed the Psychosocial Aspects of
Hereditary Cancer (PAHC) questionnaire as a tool for
identifying psychosocial issues and concerns experienced
during cancer genetic counseling [15]. The PAHC ques-
tionnaire consists of 26 items, organized into six domains.
We have established a threshold per domain of the PAHC
questionnaire for identifying counselees who may need
further psychosocial care [15].
Knowledge of the specific psychosocial problems and
distress levels experienced by counselees, as well as factors
that may be associated with such problems can provide
genetic counselors with useful information that they can
use during the genetic counseling session. In this paper, we
report on a study of the prevalence of cancer genetic
counseling-specific psychosocial problems and their asso-
ciation with more generalized distress as assessed by the
HADS and the DT. We also investigated whether so-
ciodemographic and clinical variables are associated sig-
nificantly with psychosocial problems and psychological
distress experienced during cancer genetic counseling.
Materials and methods
The data reported here were collected as a part of a larger
study that evaluated the screening properties of the PAHC
questionnaire and the DT in the cancer genetic counseling
setting [15]. The institutional review board of the hospital
approved this study, and informed consent was obtained
from all individual participants included in the study.
Participants
Individuals were eligible to participate when they were
scheduled for a visit at the family cancer clinic of The
Netherlands Cancer Institute to undergo genetic counseling
for any type of hereditary cancer syndrome in the period
January–December, 2010, were over 18 years of age, and
had a sufficient command of the Dutch language.
Procedure
Eligible counselees received a letter of invitation from the
head of the family cancer clinic and, if interested, were
requested to return a signed consent form by mail. A re-
minder letter was sent 1 week before the genetic counsel-
ing session. Participants completed a questionnaire on a
touchscreen computer at the clinic with demographic
questions, the PAHC questionnaire, the DT and the HADS.
The preference was to have the questionnaire completed
prior to the counseling, but this was not always feasible due
to planning issues. Thus counselees completed the ques-
tionnaire immediately prior to their scheduled genetic
counseling session or immediately thereafter.
Sociodemographic and clinical data
The counselees’ age, sex, marital status, education level,
number of children, the number of affected first degree
relatives, and use of psychosocial services in the past for
any problem (i.e., not necessarily in the cancer genetic
counseling setting) were obtained via self-report. Data on
whether (s)he was diagnosed with cancer in the past and, if
so, at what age, and whether there was a known gene
mutation in the family were extracted from the medical
records.
The PAHC questionnaire
The PAHC questionnaire consists of 26 questions ad-
dressing psychosocial problems and concerns that are
specifically relevant to counselees within the cancer ge-
netic counseling and testing setting. The content of the
PAHC questionnaire is organized into the following six
domains: (1) hereditary predisposition; (2) practical issues;
(3) family and social issues; (4) general emotions; (5)
living with cancer; and, for those who have children (6)
children-related issues. The number of items per domain
varies between 2 and 6. All 26 items are scored on a
4-point, Likert-type scale ranging from 1 (‘‘not at all’’) to 4
(‘‘very much’’). Based on a detailed analysis of the
screening properties of the PAHC questionnaire, a thresh-
old was established for clinical relevance [15]. Specifically,
if one or more items within a domain is rated with a 3 or a 4
(i.e., indicating a moderate to severe problem), that domain
is considered as a positive case. Additionally, per problem
domain, the respondent is asked to indicate whether (s)he
would like to receive professional psychosocial support.
The PAHC questionnaire is supplemented by the DT, a
visual analogue scale ranging from 0 to 10 (no distress to
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severe distress) [13]. The timeframe of the PAHC ques-
tionnaire and the DT is the previous week.
The HADS
The HADS was used to assess general psychological dis-
tress. It includes 14 questions and yields a total score and
subscale scores for anxiety and depression. In the current
analysis, we used only the total score, with a possible range
of 0–42. Higher scores represent higher levels of distress.
The HADS has been validated for use in the Netherlands
[16].
Statistical analysis
We used analysis of variance and Chi square analyses to
compare study participants and non-participants on so-
ciodemographic and clinical characteristics. Chi square
analysis and Student’s t tests were used to examine po-
tential differences in responses to the PAHC questionnaire,
the HADS and the DT as a function of timing of ques-
tionnaire completion (i.e., prior to or immediately follow-
ing the counseling session). The association between the
PAHC questionnaire domains, the HADS and the DT was
assessed by calculating Pearson’s correlation coefficients
and partial correlations that controlled for inter-correlations
between the domains of the PAHC questionnaire.
Chi square and Student’s t tests were employed to in-
vestigate which sociodemographic and clinical variables, if
any, were associated significantly with the PAHC ques-
tionnaire domains, the HADS, and the DT. Any variable
with a p value below 0.10 was entered subsequently into a
logistic (for the PAHC domain scores) or a linear regres-
sion model (for the HADS, and the DT). Only those par-
ticipants with children completed the domain addressing
children-related issues. Thus the analyses relating to this
domain were performed on the subgroup of participants
with children (n = 100).
Results
Participants
In total, 263 eligible counselees were invited to participate
in the study, of whom 139 (53 %) agreed to do so. Reasons
for non-participation included logistical or scheduling
problems (n = 23), perceived emotional burden (n = 20),
lack of interest (n = 13), and not wanting the counseling
session to be audiotaped (n = 3) (audiotaping was em-
ployed for another part of the study). Thirty-nine counse-
lees provided other reasons, and 26 did not provide a
reason. Two additional cases were excluded from the
analysis because their clinical data were not available. This
resulted in a total of 137 cases for the analysis. No statis-
tically significant differences were observed between study
participants and non-participants on any of the available
sociodemographic and clinical variables.
The sociodemographic characteristics of the sample are
reported in Table 1. The mean age of the sample was
47.1 years (range 18–78), and the large majority was fe-
male and being counseled for hereditary breast and ovarian
cancer syndrome (82 %). Most respondents were married
or in a steady relationship, had children, and reported that
they were not aware of any DNA-mutation in the family.
Approximately half of the sample was relatively highly
educated, had had contact with a psychologist or social
worker at some time in the past, and had previously been
diagnosed with cancer. There were no statistical significant
differences on any of these background variables between
Table 1 Sociodemographic and clinical characteristics of the study
sample (n = 137)
Participants
(n = 137)















Previous contact with psychosocial worker
Yes 69 (50)
No 68 (50)
First in family being referred to cancer genetic counseling
Yes 87 (64)
No 50 (36)
Mutation in family before counseling
Yes 33 (24)
No 104 (76)
Personal history of cancer
Yes 71 (52)
No 66 (48)
a n = 136, one participant had an unknown educational level
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those who completed the questionnaires before (n = 91) or
after (n = 46) the genetic counseling session.
Prevalence of psychosocial problems and their
relation to distress
Approximately 10 % of the participants did not report any
problems included in the PAHC questionnaire that were of
a sufficient magnitude (i.e., a score of 3 or 4 on an item
within any given domain) to be considered relevant for
further discussion. Fifty-four percent of the participants
met the threshold for clinical relevance on three or more
domains of the PAHC questionnaire (Table 2). The domain
with the highest prevalence was ‘living with cancer’
(84 %), followed by ‘hereditary predisposition’ (46 %),
‘family and social issues’ (45 %), and ‘child-related issues’
(42 %). The domains ‘general emotions’ (29 %), and
‘practical issues’ (19 %) had the lowest prevalence in our
sample (Table 3).
All of the PAHC questionnaire domains were correlated
significantly with psychological distress as measured by the
HADS, when based on a Pearson correlation coefficient.
However, when correcting for inter-domain correlations,
only the domains ‘family and social issues’ and ‘general
emotions’ remained statistically significantly associated
with the HADS. All of the partial correlations were low,
with the exception of the domain ‘general emotion,’ which
has a strong conceptual overlap with distress as assessed by
the HADS (Table 3).
The domains ‘hereditary predisposition’, ‘practical is-
sues’, and ‘general emotions’ had statistical significant
Pearson’s correlations with distress as measured by the DT.
These domains remained statistically significant when
correcting for inter-domain correlations. However, the
magnitude of the (partial) correlations was relatively low
(Table 3).
Sociodemographic and clinical variables associated
with general distress
Education level, having had previous contact with a psy-
chosocial worker, and having a personal history of cancer
were associated significantly with general distress as
measured by the HADS (see Table 4). When entered in a
linear regression model, only having had previous contact
with a psychosocial worker (p = 0.001), and having a
personal history of cancer (p = 0.03) remained statistically
significant. However, only 10 % of the variance in distress
scores was explained by these three variables.
Marital status, having had previous contact with a
psychosocial worker, having a known mutation in the
family, and having a personal history of cancer were
statistically significantly associated with the DT. How-
ever, none of these variables remained statistically sig-
nificant when entered in a linear regression model. The
variance in distress scores explained by these four vari-
ables was 8 %.
Sociodemographic and clinical variables associated
with PAHC questionnaire domains
At the univariate level, the following statistically sig-
nificant associations were observed between background
variables and the PAHC questionnaire domains: having
children with the domain ‘hereditary predisposition’; age
and having had previous contact with a psychosocial
worker with the domain ‘practical issues’; having children,
being the first in the family to undergo genetic counseling,
and sex with the domain ‘family and social issues’; having
had previous contact with a psychosocial worker and
having a personal history of cancer with the domain
‘general emotions’; and sex, the total number of children,
and a known DNA-mutation in the family with the domain
‘living with cancer’.
At the multivariate level, having children was the only
variable associated significantly with the domains ‘her-
editary predisposition’ (p = 0.02) and ‘family and social
issues’ (p = 0.007). Previous contact with a psychosocial
worker (at any time in the past, for any problem) was as-
sociated significantly with the domain ‘practical issues’
(p = 0.04). No sociodemographic or clinical variables
exhibited statistically significant associations with the do-
mains ‘general emotions’, ‘living with cancer’ or ‘child-
related issues’. The variance in the PAHC domain scores
Table 2 Frequency and
percentages of PAHC
questionnaire domains with
scores above the threshold
Frequency (n = 137) Percentage Cumulative percentage
None 14 10.2 10.2
1 domain 30 21.9 32.1
2 domains 19 13.9 46.0
3 domains 27 19.7 65.7
4 domains 27 19.7 85.4
5 domains 15 10.9 96.4
6 domains 5 3.6 100
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explained by these regression models ranged from 2 to
14 % (Table 5).
Discussion
In this paper we have reported on the prevalence of specific
psychosocial problems experienced by counselees at the
time that they attended a family cancer clinic for their first
cancer genetic counseling session. Many counselees re-
ported moderate to severe problems in the various domains
assessed by the PAHC questionnaire, such as ‘living with
cancer’, ‘hereditary predisposition’, ‘family and social is-
sues’, and ‘child-related problems’. These results are in
line with those reported by Bennett et al. [17] who, using a
different questionnaire, found that up to two-thirds of
counselees experienced concerns related to the impact of
genetic counseling and testing on family members. In our
study, 54 % of counselees reported problems on at least
three different PAHC questionnaire domains of sufficient
severity to merit discussion with the genetic counselor. It is
important that such problems are detected and discussed
during genetic counseling [18, 19], as that can lead to an
improved relationship between counselor and counselee,
and may ultimately may result in the resolution of those
problems and of associated distress [20].
Some investigators have proposed using sociodemo-
graphic and clinical risk factors or risk profiles to identify
Table 3 Percentage of counselees with PAHC questionnaire scores above the threshold for clinical relevance per domain and correlations with
the HADS and DTa
Domain Above the threshold










Hereditary predisposition 46 0.33** 0.16 0.31** 0.24**
Practical issues 19 0.23** 0.09 0.26** 0.17*
Family and social issues 45 0.33** 0.19* 0.16 0.03
General emotions 29 0.54** 0.49*** 0.29** 0.25**
Living with cancer 84 0.29** 0.14 0.14 0.02
Child-related issues 42 0.24** -0.05 0.09 -0.10
HADS Hospital Anxiety and Depression Scale, DT Distress Thermometer
* p\ 0.05; ** p\ 0.01; *** p\ 0.001
a Pearson’s correlation between HADS and DT = 0.58***
b Distress as measured with the HADS, adjusted R square of the model = 0.37
c Distress as measured with the DT, adjusted R square of the model = 0.15
d Association between variables controlling for inter-correlation between the domains
Table 4 Sociodemographic
and clinical variables associated
with general distress, assessed
with the HADS and the DT
B (SE) exp b 95 % CI for B
Lower Upper
HADSa
Education level -0.10 (0.68) -0.01 -1.45 1.26
Previous contact with psychosocial worker 3.61 (1.08)** 0.28 1.48 5.74
Personal history of cancer 2.45 (1.09)* 0.19 0.31 4.60
DTb
Marital status 1.11 (0.77) 0.12 -0.40 2.64
Previous contact with psychosocial worker 0.79 (0.47) 0.14 -0.13 1.71
Known mutation in family -0.52 (0.58) -0.08 -1.67 0.63
Personal history of cancer 0.73 (0.50) 0.13 -0.25 1.71
HADS Hospital Anxiety and Depression Scale, DT Distress Thermometer
* p\ 0.05; ** p\ 0.01
a Adjusted R square of the model = 0.10
b Adjusted R square of the model = 0.08
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individuals who are likely to be(come) distressed [11, 12].
Although we identified some variables that are associated
significantly with both generalized distress and specific
cancer genetic-specific problems, the percentage of vari-
ance explained by these variables was consistently low.
This suggests that sociodemographic and clinical variables
may not be particularly useful in identifying particularly
vulnerable counselees. Rather, such background variables
can be used as probes once a counselee reports being dis-
tressed and/or having specific psychosocial problems re-
lated to the genetic counseling process. For example, if a
counselee reports family and social issues at the time of
counseling, the counselor can inquire further about the
potential role of having children and of being the first in the
family being referred to genetic counseling.
We would stress the potential importance of asking
counselees about their specific psychosocial problems at
the time of cancer genetic counseling, prior to undergoing
DNA testing and receiving the DNA test results. Studies of
the routine use of patient-reported outcome measures in
daily clinical oncology practice have demonstrated their
value in enhancing communication between patients and
their health care providers [21–25]. We have conducted a
randomized controlled trial, using the PAHC questionnaire,
which showed the promising potential of the questionnaire
as a valuable first-line screening instrument in the cancer
clinical genetics setting [26–28].
There are several limitations of the current study that
should be noted. First, only 53 % of those invited to par-
ticipate in the study actually did so. Although we did not
observe any statistically significant differences between
participants and non-participants on sociodemographic or
clinical background variables, we cannot say with certainty
that our sample was entirely representative of the larger
population of interest. However, while a small minority of
the non-participants (20 of 124 = 16 %) indicated that they
thought the study would be too emotionally burdensome for
them (suggesting underling psychosocial problems and/or
distress), the majority of non-participants either reported
more neutral reasons (e.g., logistical problems, lack of in-
terest, not wanting to be audiotaped, etc.) or did not provide
a reason. Second, the large majority of study participants
was female and was being counseled for hereditary breast
and ovarian cancer, reflecting the population of counselees
attending the family cancer clinical at the Netherlands
Cancer Institute. However, our results cannot necessarily be
generalized to those with other hereditary syndromes. As
we did not have sufficient statistical power to do so, future
studies are needed to determine if the prevalence of psy-
chosocial problems varies significantly as a function of
hereditary cancer syndrome and of sex. Third, the PAHC
questionnaire was administered either prior to or immedi-
ately following the genetic counseling session. This could
potentially affect the observed prevalence of psychosocial
Table 5 Sociodemographic and clinical variables associated with PAHC questionnaire domains




Having children 0.94 (0.41)* 2.56 1.14 5.74
Constant -0.86 (0.36)* 0.42
Practical issues 0.10
Age -0.37 (0.02) 0.96 0.93 1.00
Previous contact with psychosocial worker -0.97 (0.47)* 0.38 0.15 0.96
Family and social issues 0.14
Having children 1.27 (0.47)** 3.56 1.41 8.94
First in family to undergo genetic counseling 0.72 (0.39) 2.06 0.96 4.39
Sex -0.33 (0.54) 0.72 0.25 2.06
General emotions 0.06
Previous contact with psychosocial worker -0.57 (0.39) 0.57 0.27 1.21
Personal history of cancer -0.75 (0.39) 0.47 0.22 1.02
Living with cancer 0.02
Sex -0.35 (0.87) 0.71 0.13 3.91
Total number of children 0.29 (0.38) 1.33 0.64 2.79
Known mutation in family 0.53 (0.68) 1.70 0.45 6.42
The domain of ‘child-related issues’ did not yield any statistical significant factors
PAHC Psychosocial Aspects of Hereditary Cancer questionnaire
* p\ 0.05; ** p\ 0.01
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problems and the associations observed between the PAHC
questionnaire and the HADS and DT, and between the
PAHC questionnaire and various sociodemographic and
clinical variables. However, our analyses indicated that the
prevalence of psychosocial problems did not vary sig-
nificantly as a function of the timing of the questionnaire
administration. Fourth, the domains of the PAHC ques-
tionnaire were correlated. While this could potentially
complicate the interpretation of observed correlations be-
tween the PAHC and other measures and variables, the use
of partial correlations corrected for this.
The study also had several important strengths. First, as
indicated above, the study sample was representative of the
population undergoing genetic counseling in our clinic. Se-
cond, we included a range of sociodemographic and clinical
variables that have been frequently used to try to identify
those at risk for psychosocial problems and psychological
distress. Thus we were able to compare directly the relative
value of risk profiles based on background variables with a
psychosocial screening questionnaire in identifying those
with clinically relevant psychosocial problems.
In conclusion, although only a minority of individuals
who undergo cancer genetic counseling suffer from high
levels of psychological distress, the large majority reports a
range of psychosocial problems related specifically to
cancer genetic counseling. The PAHC questionnaire is a
useful tool for identifying relevant psychosocial problems
that merit further attention in clinical practice. Use of such
a tool can contribute significantly to enhancing the quality
of communication between genetic counselors and their
clients, to providing client-centered care, and to addressing
relevant psychosocial problems in a timely manner.
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